Variant report
Variant | nsv890015 |
---|---|
Chromosome Location | chr8:5719971-5763806 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANGPT2-13 | chr8:5738563-5738710 | l_3534_chr8:5703213-5738710_testes |
2 | lnc-ANGPT2-6 | chr8:5757144-5757253 | XLOC_006982 |
3 | lnc-ANGPT2-6 | chr8:5751155-5751303 | XLOC_006982 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533039441 | chr8:5732804-5732805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186582310 | chr8:5732814-5732815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150683037 | chr8:5732837-5732838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78427210 | chr8:5732843-5732844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543219780 | chr8:5732845-5732846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192043179 | chr8:5732849-5732850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528566672 | chr8:5732874-5732875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181860454 | chr8:5732895-5732896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs565030315 | chr8:5732938-5732939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs139701408 | chr8:5732948-5732949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550683542 | chr8:5732949-5732950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116802240 | chr8:5732958-5732959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149764977 | chr8:5732960-5732961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548366417 | chr8:5732961-5732962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs78901034 | chr8:5732965-5732966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371368824 | chr8:5732973-5732974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558716276 | chr8:5732974-5732975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144747286 | chr8:5732984-5732985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537864488 | chr8:5732999-5733000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555859629 | chr8:5733001-5733002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575898019 | chr8:5733019-5733020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542912370 | chr8:5733034-5733035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554833936 | chr8:5733046-5733047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112046199 | chr8:5733050-5733051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375953015 | chr8:5733053-5733054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116496732 | chr8:5733055-5733056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565071497 | chr8:5733065-5733066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532464524 | chr8:5733085-5733086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544613758 | chr8:5733120-5733121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139603168 | chr8:5733123-5733124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530009012 | chr8:5733141-5733142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548540710 | chr8:5733148-5733149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566754516 | chr8:5733149-5733150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527519967 | chr8:5733151-5733152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552368556 | chr8:5733181-5733182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs57392994 | chr8:5733186-5733187 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs144117439 | chr8:5733188-5733189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556134582 | chr8:5733206-5733207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189651668 | chr8:5733218-5733219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535428001 | chr8:5733220-5733221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537850485 | chr8:5733222-5733223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565507672 | chr8:5733227-5733228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554870762 | chr8:5733231-5733232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182084350 | chr8:5733233-5733234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187943039 | chr8:5733236-5733237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75116820 | chr8:5733243-5733244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs11781503 | chr8:5733247-5733248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs60405165 | chr8:5733263-5733264 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs368182442 | chr8:5733278-5733279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571689054 | chr8:5733281-5733282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Schizophrenia | 20967226 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5732800-5735400 | Weak transcription | Fetal Heart | heart |
2 | chr8:5735400-5735600 | Enhancers | Fetal Heart | heart |
3 | chr8:5755000-5755400 | Active TSS | Hela-S3 | cervix |
4 | chr8:5759400-5759600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr8:5759400-5759600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr8:5759600-5760200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr8:5759800-5761000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr8:5760200-5761600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr8:5760800-5761600 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr8:5761000-5761400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr8:5761000-5761600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr8:5761400-5762000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:5761400-5763400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr8:5761600-5762000 | Weak transcription | H1 Cell Line | embryonic stem cell |
15 | chr8:5761600-5763400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr8:5761600-5763400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
17 | chr8:5762000-5762200 | Enhancers | H1 Cell Line | embryonic stem cell |
18 | chr8:5762000-5762200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr8:5762000-5762400 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
20 | chr8:5762200-5764000 | Weak transcription | H1 Cell Line | embryonic stem cell |
21 | chr8:5762200-5764600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
22 | chr8:5763400-5763600 | Enhancers | H9 Cell Line | embryonic stem cell |
23 | chr8:5763400-5764200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
24 | chr8:5763400-5764600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
25 | chr8:5763400-5765600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
26 | chr8:5763400-5765800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
27 | chr8:5763600-5764200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
28 | chr8:5763600-5764600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
29 | chr8:5763800-5764600 | Weak transcription | H9 Cell Line | embryonic stem cell |